Interleukin-2 (low-dose)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Interleukin-2 (low-dose), covering 2018-10-18 to 2025-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients [Phase 1]